Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Somatostatin Receptor”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Early research (Phase 1)Looking for participantsNCT06479811
What this trial is testing

[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers

Who this might be right for
Head and Neck TumorsKidney CancersSmall Cell Lung Cancers+3 more
National Cancer Institute (NCI) 120
Not applicableStudy completedNCT05844332
What this trial is testing

LUTATHERA Injection General Use Result Survey

Who this might be right for
Somatostatin Receptor-positive Neuroendocrine Tumor
Novartis Pharmaceuticals 347
Testing effectiveness (Phase 2)Study completedNCT01619865
What this trial is testing

Safety of 68Ga-DOTA-tyr3-Octreotide PET in Diagnosis of Solid Tumors

Who this might be right for
Neuroendocrine TumorsCarcinoid TumorsNeuroblastoma+1 more
Sue O'Dorisio 223
Large-scale testing (Phase 3)Study completedNCT01460706
What this trial is testing

Imaging Malignant Glioma With 68Ga-DOTATOC PET/CT

Who this might be right for
Glioma
Turku University Hospital 30
Large-scale testing (Phase 3)UnknownNCT03252353
What this trial is testing

Efficacy and Safety of Octreotide Capsules (MYCAPSSA) in Acromegaly

Who this might be right for
Acromegaly
Chiasma, Inc. 56
Not applicableNo Longer AvailableNCT01980732
What this trial is testing

68Ga DOTA-TATE PET/CT in Somatostatin Receptor Positive Tumors

Who this might be right for
Carcinoid TumorsIslet Cell (Pancreatic NET)Other Neuroendocrine Tumors
Andrei Iagaru
Testing effectiveness (Phase 2)Study completedNCT05183555
What this trial is testing

Early Feasibility Study of Somatostatin Receptors PET Imaging for the Diagnosis of Infective Endocarditis

Who this might be right for
Infective Endocarditis
Central Hospital, Nancy, France 14
Early research (Phase 1)Study completedNCT03883776
What this trial is testing

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

Who this might be right for
Neuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 12
Testing effectiveness (Phase 2)Looking for participantsNCT03145857
What this trial is testing

Evaluate a New Way to Identify/Diagnose Tumours With Somatostatin Receptors Using [68]Ga-HA-DOTATATE and to Ensure it is Safe to Use

Who this might be right for
Neuroendocrine Tumors
AHS Cancer Control Alberta 1,534
Very early researchUnknownNCT01524016
What this trial is testing

68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia

Who this might be right for
Oncogenic OsteomalaciaMesenchymal Tumor
Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)Looking for participantsNCT05278208
What this trial is testing

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Who this might be right for
High Grade GliomaMeningiomaEmbryonal Tumor+10 more
Nationwide Children's Hospital 65
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135
What this trial is testing

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Advanced Accelerator Applications 11
Testing effectiveness (Phase 2)Looking for participantsNCT04927416
What this trial is testing

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Who this might be right for
Metastic Thyroid Cancer
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 54
Not applicableNo Longer AvailableNCT02174679
What this trial is testing

68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access)

Who this might be right for
Carcinoid CancerNeuroendocrine TumorsMedullary Thyroid Cancer+1 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Early research (Phase 1)Ended earlyNCT03466216
What this trial is testing

Phase 1 Study of AlphaMedix™ in Adult Subjects With SSTR (+) NET

Who this might be right for
Neuroendocrine Tumor
Orano Med LLC 33
Testing effectiveness (Phase 2)UnknownNCT04194125
What this trial is testing

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Who this might be right for
Neuroendocrine Tumors
University of Warmia and Mazury 25
Testing effectiveness (Phase 2)Active Not RecruitingNCT05724108
What this trial is testing

Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors

Who this might be right for
Metastatic Neuroendocrine Tumor
National Cancer Institute (NCI) 94
Large-scale testing (Phase 3)Active Not RecruitingNCT03049189
What this trial is testing

Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 324
Not applicableStudy completedNCT05680675
What this trial is testing

Dual-Tracer Theranostic PET

Who this might be right for
Neuroendocrine TumorsProstate Cancer
University of Utah 50
Load More Results